Hot

i-Health, Inc. Urges U.S. Congressional Leaders to Prioritize the Funding of Natural & Non-Hormonal Solutions for Menopause in Women's Health Research

Retrieved on: 
Monday, April 8, 2024
Health, Attention, Congress, Government, Veteran, White, SVP, Executive order, Research, Menopause, History, Woman, Data collection, Hormone replacement therapy, Breast cancer, HRT, Hot, Amerifit Brands

i-Health, Inc. starts discussions with Congress to enhance research and funding for non-hormonal menopause options.

Key Points: 
  • i-Health, Inc. starts discussions with Congress to enhance research and funding for non-hormonal menopause options.
  • Research gaps are especially prevalent for health conditions associated with women's midlife and later years, including perimenopause and menopause."
  • The latest Executive Order from President Biden aims to close research gaps on women's health across their lifespans.
  • i-Health, Inc. the company behind Estroven®, the leading brand in natural, non-hormonal menopause relief‡, is committed to driving meaningful change for often overlooked health issues.

#VelocitySeries 2.0 Launch Alert: Dive into The Era of Data-Driven, Divisible Art with Bybit's Exclusive Livestream with Oracle Red Bull Racing

Retrieved on: 
Friday, April 5, 2024
AOI, World championship, F1, Pop-punk, Fraction, NFT, Formula, Divisor, Non-fungible token, UTC, Hot, Velocity, Cryptocurrency

The live event promises exciting insights and a chance to win incredible prizes, including the coveted Velocity Pass 2.0.

Key Points: 
  • The live event promises exciting insights and a chance to win incredible prizes, including the coveted Velocity Pass 2.0.
  • Meet the Velocity Series 2.0 Powerhouse Panel:
    Max Wu, Bybit Web3: Get firsthand insights from Bybit's Web3 team.
  • Dan Mitchell, Oracle Red Bull Racing: Dive deep into the world of F1 with a representative from the championship-winning team.
  • Exclusive Reveals and Hot Topics:
    Celebrate 20 Years of Oracle Red Bull Racing Glory: Witness the fusion of cutting-edge technology and artistic expression as we commemorate Oracle Red Bull Racing's two-decade reign.

#VelocitySeries 2.0 Launch Alert: Dive into The Era of Data-Driven, Divisible Art with Bybit's Exclusive Livestream with Oracle Red Bull Racing

Retrieved on: 
Friday, April 5, 2024
AOI, World championship, F1, Pop-punk, Fraction, NFT, Formula, Divisor, Non-fungible token, UTC, Hot, Velocity, Cryptocurrency

The live event promises exciting insights and a chance to win incredible prizes, including the coveted Velocity Pass 2.0.

Key Points: 
  • The live event promises exciting insights and a chance to win incredible prizes, including the coveted Velocity Pass 2.0.
  • Meet the Velocity Series 2.0 Powerhouse Panel:
    Max Wu, Bybit Web3: Get firsthand insights from Bybit's Web3 team.
  • Dan Mitchell, Oracle Red Bull Racing: Dive deep into the world of F1 with a representative from the championship-winning team.
  • Exclusive Reveals and Hot Topics:
    Celebrate 20 Years of Oracle Red Bull Racing Glory: Witness the fusion of cutting-edge technology and artistic expression as we commemorate Oracle Red Bull Racing's two-decade reign.

Atossa Therapeutics Provides Five-Year (Z)-Endoxifen Treatment Update on FDA-Approved "Expanded Access" Program for a U.S. Breast Cancer Patient

Retrieved on: 
Tuesday, March 19, 2024
Diagnosis, Growth, Ki-67, Neoadjuvant therapy, Mammography, Cancer, Expanded access, Woman, Neoplasm, Therapy, Breast cancer, CYP2D6, Safety, Axis, Osteoporosis, Hot, Recurrence, Tamoxifen, FDA, Enzyme inhibitor, PR, Pharmaceutical industry

Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer.

Key Points: 
  • Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer.
  • Over five years of adjuvant treatment, her daily (Z)-endoxifen treatment has been well tolerated, and there were no vasomotor symptoms commonly associated with standard of care adjuvant pharmaceuticals.
  • She remains cancer-free today and we are grateful to have been able to help her with a difficult treatment problem.”
    Diagnosis.
  • Under the FDA Expanded Access IND program, the use of Atossa's proprietary (Z)-endoxifen is restricted to this patient only.

Hot Wheels Unveils New Die-Cast to Encourage Open-Ended Play Ahead of Autism Acceptance Month

Retrieved on: 
Tuesday, March 26, 2024
People with Disabilities, Parenting, Children, Entertainment, Toys, Other Entertainment, Family, Consumer, Retail, Licensing (Entertainment), Partnership, Hot Wheels, ASAN, Motion, Love, Autistic Self Advocacy Network, Multimedia, SRP, Spectrum, Hot, Toy

Today, Mattel, Inc. (NASDAQ: MAT) announced the Hot Wheels® Flippin Fast™ die-cast, a new vehicle designed to encourage an open-ended play experience, ahead of Autism Acceptance Month in April.

Key Points: 
  • Today, Mattel, Inc. (NASDAQ: MAT) announced the Hot Wheels® Flippin Fast™ die-cast, a new vehicle designed to encourage an open-ended play experience, ahead of Autism Acceptance Month in April.
  • The Flippin Fast die-cast ignites the challenger spirit as one of the most versatile die-cast vehicles from Hot Wheels.
  • View the full release here: https://www.businesswire.com/news/home/20240326156181/en/
    Mattel's Hot Wheels® Flippin Fast™ die-cast, a new vehicle designed to encourage an open-ended play experience, was developed in partnership with the Autistic Self Advocacy Network (ASAN).
  • Hot Wheels Flippin Fast is now available on-shelf at retailers nationwide for $1.25 SRP, right next to all the other Hot Wheels toys fans know and love.

Mattel Adventure Park Kansas City Set for 2026 Opening

Retrieved on: 
Wednesday, March 20, 2024
Theme Parks, Men, Entertainment, Toys, Family, Consumer, General Entertainment, Teens, Retail, Children, Women, Licensing (Entertainment), Seniors, Magic, Partnership, Hot Wheels, Adventure park, Castle Grayskull, Life, Master, Ultimate Ride, Multimedia, Hot, Amusement park

Mattel, Inc. (NASDAQ: MAT), through a licensing partnership with Epic Resort Destinations, today announced plans for a second Mattel Adventure Park location in an all-new entertainment resort destination located in Bonner Springs, Kansas.

Key Points: 
  • Mattel, Inc. (NASDAQ: MAT), through a licensing partnership with Epic Resort Destinations, today announced plans for a second Mattel Adventure Park location in an all-new entertainment resort destination located in Bonner Springs, Kansas.
  • The all-new, family-friendly themed entertainment destination is set to open in 2026, with plans to break ground later this year.
  • View the full release here: https://www.businesswire.com/news/home/20240320653241/en/
    Mattel Adventure Park Kansas City will offer the highly anticipated attractions of Mattel Adventure Park Glendale, Arizona, including fully themed Hot Wheels roller coasters such as the Hot Wheels™ Bone Shaker®: The Ultimate Ride and the Hot Wheels™ Twin Mill® Racer.
  • “Mattel Adventure Park Kansas City will bring our iconic brands to life with epic roller coasters, family-friendly attractions, an immersive theatre, themed dining, and so much more,” said Josh Silverman, Chief Franchise Officer at Mattel.

Positive topline results from Phase III long-term study OASIS 3 support submissions for marketing authorization for Bayer’s elinzanetant

Retrieved on: 
Tuesday, March 19, 2024
Health, Fitness & Nutrition, Clinical Trials, Research, Pharmaceutical, Science, International Menopause Society, VMS, Menopause, OASIS, Executive Committee, Imperial College London, Woman, Hot, Safety, Elinzanetant, Phase, Marketing, Pharmaceutical industry

Bayer today announced positive topline results of the Phase III study OASIS 3 evaluating the efficacy and long-term safety of the investigational compound elinzanetant versus placebo.

Key Points: 
  • Bayer today announced positive topline results of the Phase III study OASIS 3 evaluating the efficacy and long-term safety of the investigational compound elinzanetant versus placebo.
  • The long-term safety profile observed over 52 weeks in the OASIS 3 study is overall consistent with previously conducted studies and published data1,2 on elinzanetant.
  • “OASIS 3 was designed to address the important question of the long-term profile of elinzanetant.
  • “These results, coupled with the recent announcement of topline data for OASIS 1 and OASIS 2, strengthen our confidence in the proposed efficacy and safety of elinzanetant as a potential novel non-hormonal solution for women experiencing menopause-related symptoms.”
    OASIS 3 (NCT05030584) is the third Phase III study in the OASIS clinical development program with positive topline results.

Blex Introduces Revolutionary Dual-Pulse Technology to IPL Hair Removal Device

Retrieved on: 
Tuesday, April 2, 2024
Temperature, Burns, Risk, IPL, Hair removal, Pulse, Skin, Safety, Skin temperature, Sony, Hot, Sapphire, FDA

NEW YORK, April 2, 2024 /PRNewswire/ -- Blex, a pioneer in dermatologist-endorsed beauty care, is excited to present their newest product, the Blex Hair Removal Device.

Key Points: 
  • NEW YORK, April 2, 2024 /PRNewswire/ -- Blex, a pioneer in dermatologist-endorsed beauty care, is excited to present their newest product, the Blex Hair Removal Device.
  • If you've scrolled through BeautyTok recently, there's a good chance you've come across some reviews of an at-home IPL hair removal device.
  • Blex's Key User-oriented Features Include:
    Dual-Pulse Technology, offered by Blex, revolutionized at-home IPL hair removal by bringing a technique that was previously only accessible for high-end clinical equipment.
  • Rest assured, Blex is an FDA-cleared Class II medical device, offering superior safety and efficacy in at-home hair removal.

Embr Wave thermal wearable now available by subscription through unique "Embrship" offering

Retrieved on: 
Tuesday, April 2, 2024
Temperature, Entrepreneurship, Sleep, Woman, Shames, Hot

BOSTON, April 2, 2024 /PRNewswire/ -- Embr Labs , Inc, makers of Embr Wave®, the leading temperature wearable, today announced the official launch of its "Embrship" subscription which makes the award-winning device available to experience for just $20 per month.

Key Points: 
  • BOSTON, April 2, 2024 /PRNewswire/ -- Embr Labs , Inc, makers of Embr Wave®, the leading temperature wearable, today announced the official launch of its "Embrship" subscription which makes the award-winning device available to experience for just $20 per month.
  • Now, consumers have two options: the Embr Wave can be purchased outright, or customers can subscribe to the Embrship, where the device is provided free of charge along with a comprehensive membership package that includes additional, ongoing benefits as well as with a lifetime warranty.
  • The Embr Wave is available to more people than ever before with this new US-based subscription option and recent sales channel expansion in the UK and Canada.
  • The announcement follows Embr Labs' pivotal sleep study demonstrating the device's impact on improving sleep quality in both men and women.

Unique online yoga platform offers lifeline for menopausal women

Retrieved on: 
Friday, March 29, 2024
Arthralgia, Freedom, Brain, Chemical oxygen demand, Gamer, Yoga, Accreditation, Menopause, FREE, Anxiety, DSM-IV codes, Quality of life, PMS, Life, Woman, Yoga nidra, Hot, Grammatical mood, Fatigue, Health care

MIAMI, March 29, 2024 /PRNewswire/ -- A unique online platform, My Yoga Journey , has been launched by Yourself Yoga for Menopause to provide yoga exclusively for women in menopause who prefer a natural solution to help alleviate their symptoms.

Key Points: 
  • MIAMI, March 29, 2024 /PRNewswire/ -- A unique online platform, My Yoga Journey , has been launched by Yourself Yoga for Menopause to provide yoga exclusively for women in menopause who prefer a natural solution to help alleviate their symptoms.
  • Founded by menopause yoga expert, Julie Ann Garrido , who is one of only 600 yoga teachers worldwide with specialist menopause yoga accreditation, My Yoga Journey , offers a lifeline to menopausal women who are looking to practice yoga for menopause, but are unable to access classes locally.
  • By incorporating a mix of yoga styles including Slow Flow Yoga, Yin Yoga, Restorative Yoga, and Yoga Nidra, menopause yoga is able to address a wide range of physical, mental, and emotional changes that this phase of life can bring.
  • Yoga tutorials: so that women can learn the fundamentals of yoga, the platform includes tutorials covering all the key yoga poses.